Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.
about
Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancerHidden association of Cowden syndrome, PTEN mutation and meningioma frequencyMolecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt SignallingBrain tumors: Special characters for research and bankingSpinal cord tumours: advances in genetics and their implications for treatmentMaternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progressionDisruption of 14-3-3 binding does not impair Protein 4.1B growth suppressionDNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature.Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.Gene expression analysis of aberrant signaling pathways in meningiomasUpdate on meningiomas.Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours.Meningioma and schwannoma risk in adults in relation to family history of cancer.Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.Diagnosis and treatment of atypical and anaplastic meningiomas: a review.Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas.Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome.The WHO classification of tumors of the nervous system.Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.Fatty acid synthase as a novel target for meningioma therapy.Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas.Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma.Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma'Putting our heads together': insights into genomic conservation between human and canine intracranial tumorsBrain tumours: classification and genesDNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.Specific genes expressed in association with progesterone receptors in meningioma.Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcomeAlterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomasMolecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays.Meningioma pathology, genetics, and biology.Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridizationAlternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma.Chromosomal imbalances in choroid plexus tumors.Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?Genetic/molecular alterations of meningiomas and the signaling pathways targeted.Advanced molecular cytogenetics in human and mouseEarly recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone
P2860
Q24595803-ECCE7ED1-C450-4D93-97DC-893AA927B534Q26739125-3325100B-3AA3-40CF-A503-B57A32091F49Q26739662-EADF6644-7C60-4683-B96D-117A39272375Q26820849-557E744A-42B5-485C-BB46-F0262E03508BQ26851596-3E7D6C03-C0E7-4B69-9AFE-45484D8836EDQ28115872-8B463DE9-B06B-4A3F-AD52-94EC50C05F55Q28259119-BE06BC33-1994-4549-A7CF-FD342FD27468Q30359384-CC2BB0B8-3C2B-4890-9A0F-DA1E48B5E720Q30440977-8B322D27-CAD9-42E3-9D59-A4FC75B0A722Q30447293-604101F2-0BCC-4A23-B14D-87887E8279B1Q30450850-BBFF1214-19E8-41D1-9F0D-C194E2BA631DQ30461960-B0F5331F-7752-47DE-8949-18539045D558Q30477880-51191FE8-3DE8-4901-AD6B-2E6FC975CB10Q30542025-EBB6DE3C-0038-4B2C-B5B1-573C979010B5Q30543997-6013B474-DC04-45F2-BAFA-2873BA51DDE9Q30855737-F48ADE35-B901-489E-B191-04CCAB004628Q31003450-87BA6F17-12C3-4ECC-A0C2-A1E476F270E5Q33480310-ABB5D15D-2FD5-44F1-8DDA-9C896A49FC4DQ33760861-B83F9E46-5B3C-4C4C-A6BE-C8F3D04FC65EQ33845646-BD26A093-DBC6-452E-972D-8ABB50588AF9Q34078091-ACA8A382-C6A5-469E-B8D2-B030C43452F6Q34133066-B844933A-05DF-4963-9D62-6B73EB244BFEQ34480652-ABA36AF2-5261-4A22-A602-5AEF795DB07EQ34625269-E78CBCCB-D96A-4BF6-96E7-7CEE0241D0B9Q35072568-0F8FE347-3CCA-4A18-BCE0-111614A0157EQ35575628-2C842200-DC99-4961-A387-D694EEA2C3DBQ35576526-F79179A2-9B32-4113-9903-36D7821C9B00Q35584376-CFB84B61-12EA-4D72-8BB0-5240E7672F70Q35668372-426EB409-2710-49E8-9487-2FA0450815D1Q35745691-37A15F84-2BD9-4D9D-8C74-F3F3452356B5Q35747010-446B9BB3-DD31-4EB5-8B6E-85B268A61369Q35747646-08FC2AEA-F0C6-4122-BAB4-9CCFF3A3BD05Q35751662-2988942E-D5CA-4085-A5C3-176971768470Q35753191-87B45469-704D-4359-BC6D-4C38CB10E0E8Q35763880-1A9EAFA9-9026-408C-B72B-13A8C943F173Q35788860-629695ED-2DBB-460C-84CB-A96C4EE0E27EQ35789787-E3E78A58-4400-411D-A04F-CA3EB1A2A026Q35793582-E6B41918-527D-44F2-82FC-014B17D26AB9Q35878284-34E5B7ED-3CF8-4589-A737-E7E18D71052CQ36013346-7A7AE6B8-3CD2-4A8E-A1DD-614E5EAD8993
P2860
Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Analysis of genomic alteration ...... del of meningioma progression.
@en
type
label
Analysis of genomic alteration ...... del of meningioma progression.
@en
prefLabel
Analysis of genomic alteration ...... del of meningioma progression.
@en
P2093
P2860
P356
P1476
Analysis of genomic alteration ...... del of meningioma progression.
@en
P2093
P2860
P304
14719-14724
P356
10.1073/PNAS.94.26.14719
P407
P577
1997-12-01T00:00:00Z